Showing 5661-5670 of 19383 results for "".
Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
https://reachmd.com/programs/project-oncology/cardiac-complications-in-sickle-cell-disease-emerging-evidence-and-risks/35929/Cardiopulmonary complications are a leading cause of early mortality in adults with sickle cell disease, with evidence showing that cardiac injury may begin as early as childhood. However, despite the severity of these issues, there are currently no uniform guidelines for asymptomatic cardiac screenThe Transition from Pediatric to Adult Care for Patients with Sickle Cell Disease
https://reachmd.com/programs/project-oncology/the-transition-from-pediatric-to-adult-care-for-patients-with-sickle-cell-disease/36448/Effective transition from pediatric to adult care should begin as early as age twelve for patients with sickle cell disease, incorporating factors like education, self-advocacy skills, and support from transition care coordinators. Tune in to hear Dr. Nidhi Bhatt, who works in the Department of HemaJournal Club: Colloidal Oat for Prevention and Treatment
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-colloidal-oat-for-prevention-and-treatment/32407/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Lawrence Eichenfield, MD, FAAD, discuss a study demonstrating the benefits of oat for infant skincare, especially for the treatment and mitigation of atopic dermatitis.Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
https://reachmd.com/programs/frontlines-migraine/assessing-sex-based-treatment-responses-to-gepants-in-migraine-management/36157/A secondary analysis of eight clinical trials assessed the efficacy of ubrogepant and atogepant in both acute and preventive migraine treatments. Dive into these findings and explore implications for the future of migraine care.Driving Wound Care Forward: AI, Wearables, and Point-of-Care Diagnostics
https://reachmd.com/programs/clinicians-roundtable/driving-wound-care-forward-ai-wearables-and-point-of-care-diagnostics/36088/The integration of near-infrared spectroscopy, bacterial fluorescence, and AI-powered imaging is accelerating precision in wound management. Discover how sensor technology, smart bandages, and real-time data from wearables are standardizing care, reducing variability, and enabling faster clinical deOptimizing Nutrition in Patients with Chronic Liver Disease
https://reachmd.com/programs/gi-insights/optimizing-nutrition-in-patients-with-chronic-liver-disease/35592/Sarcopenia and poor nutrition are often silent threats in chronic liver disease, yet they drastically impact outcomes. Joining Dr. Peter Buch to discuss strategies for recognizing and addressing malnutrition early to improve long-term liver health is Dr. Ashwani Singal. Dr. Singal is a Professor ofGEP Testing for Cutaneous Squamous Cell Carcinoma
https://reachmd.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.Dupixent Approved for Spontaneous Urticaria
https://reachmd.com/series/dermwire-tv/dupixent-approved-for-spontaneous-urticaria/35635/In this week's DermwireTV, the FDA approves the first new therapy for spontaneous urticaria in more than 10 years; a new study examines investigational oral Icotrokinra in adolescents with plaque psoriasis; and Practical Dermatology launches a new series addressing trends and innovations in the treaUnderstanding the Pathophysiology Behind ATTR-CM
https://reachmd.com/programs/heart-matters/understanding-the-pathophysiology-behind-attr-cm/32902/Explore the mechanisms behind transthyretin amyloid cardiomyopathy, a rare condition involving protein misfolding in the heart.Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
https://reachmd.com/programs/frontlines-schizophrenia/schizophrenia-care-managing-symptoms-with-muscarinic-receptor-agonists/30028/Hear insights on muscarinic receptors antagonists and how they compare to dopamine blockage as a treatment for positive schizophrenia symptoms.